FR17C0007I2 - Procédé d'obtention du NGF-bêta biologiquement actif - Google Patents
Procédé d'obtention du NGF-bêta biologiquement actifInfo
- Publication number
- FR17C0007I2 FR17C0007I2 FR17C0007C FR17C0007C FR17C0007I2 FR 17C0007 I2 FR17C0007 I2 FR 17C0007I2 FR 17C0007 C FR17C0007 C FR 17C0007C FR 17C0007 C FR17C0007 C FR 17C0007C FR 17C0007 I2 FR17C0007 I2 FR 17C0007I2
- Authority
- FR
- France
- Prior art keywords
- ngf
- biologically active
- beta
- preparation
- proform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98119077A EP0994188B1 (de) | 1998-10-09 | 1998-10-09 | Verfahren zur Gewinnung von aktivem Beta-NGF |
Publications (2)
Publication Number | Publication Date |
---|---|
FR17C0007I1 FR17C0007I1 (fr) | 2017-11-17 |
FR17C0007I2 true FR17C0007I2 (fr) | 2018-11-09 |
Family
ID=8232766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR17C0007C Active FR17C0007I2 (fr) | 1998-10-09 | 2017-09-27 | Procédé d'obtention du NGF-bêta biologiquement actif |
Country Status (13)
Country | Link |
---|---|
US (2) | US8318671B1 (ja) |
EP (1) | EP0994188B1 (ja) |
JP (2) | JP4634611B2 (ja) |
KR (1) | KR100593831B1 (ja) |
AT (1) | ATE257514T1 (ja) |
AU (1) | AU765810B2 (ja) |
CA (1) | CA2346257C (ja) |
DE (1) | DE59810555D1 (ja) |
ES (1) | ES2213861T3 (ja) |
FR (1) | FR17C0007I2 (ja) |
NL (1) | NL300894I2 (ja) |
WO (1) | WO2000022119A1 (ja) |
ZA (1) | ZA200102780B (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE257514T1 (de) | 1998-10-09 | 2004-01-15 | Scil Proteins Gmbh | Verfahren zur gewinnung von aktivem beta-ngf |
EP1891966B1 (en) | 2002-12-20 | 2012-02-15 | H. Lundbeck A/S | Modulation of activity of neurotrophins; screening method |
SI3225251T1 (sl) | 2006-12-21 | 2020-03-31 | H. Lundbeck A/S | Modulacija aktivnosti pronevrotrofinov |
RS56893B1 (sr) | 2011-12-19 | 2018-04-30 | Wacker Chemie Ag | Novi prongf mutanti i njihove upotrebe u proizvodnji beta-ngf |
CN103880943A (zh) * | 2014-01-20 | 2014-06-25 | 厦门北大之路生物工程有限公司 | 一种rhNGF成熟肽的制备方法 |
CN106519024A (zh) * | 2015-09-15 | 2017-03-22 | 三生国健药业(上海)股份有限公司 | 一种用于去除单克隆抗体中异构体的复性液及复性方法 |
EP3406259A1 (en) | 2017-05-24 | 2018-11-28 | Dompé farmaceutici S.p.A. | Neurotrophins for use in the treatment of hearing loss |
CN108467428A (zh) * | 2018-03-26 | 2018-08-31 | 江苏中新医药有限公司 | 一种清除rhNGF中N端截短及异常变异体的方法 |
WO2019207106A1 (en) | 2018-04-27 | 2019-10-31 | Chiesi Farmaceutici Spa | Production of nerve growth factor (ngf) and of muteins thereof |
AU2019343514A1 (en) | 2018-09-17 | 2021-04-15 | Chiesi Farmaceutici S.P.A. | Agent for treatment of dermatological disorders |
CN110093394B (zh) * | 2019-05-10 | 2023-10-03 | 重庆科润生物医药研发有限公司 | 一种蛋白包涵体及重组人β-神经生长因子的制备方法 |
KR20220063190A (ko) | 2019-09-17 | 2022-05-17 | 키에시 파르마슈티시 엣스. 피. 에이. | 안과 장애의 치료 또는 예방에 사용하기 위한 제제 |
IL302317A (en) | 2020-10-28 | 2023-06-01 | Dompe Farm Spa | Pharmaceutical packaging including polypropylene containers and aqueous formulations of NGF packed in them |
EP4039269A1 (en) | 2021-02-05 | 2022-08-10 | Dompe' Farmaceutici S.P.A. | Ngf isoform for use in the treatment of ocular pathologies |
US20240197829A1 (en) | 2021-04-13 | 2024-06-20 | Dompé Farmaceutici S.P.A | Treatment of neuropathic corneal pain with ngf |
EP4311554A1 (en) | 2022-07-29 | 2024-01-31 | Dompé farmaceutici S.p.a. | Combination for use in ophthalmology |
EP4316505A1 (en) | 2022-08-05 | 2024-02-07 | Dompé farmaceutici S.p.a. | Intranasal administration of ngf for the treatment of sensorineural hearing loss |
EP4342485A1 (en) | 2022-09-23 | 2024-03-27 | Dompe' Farmaceutici S.P.A. | Ngf for the treatment of spasticity |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169762A (en) * | 1983-03-03 | 1992-12-08 | Genentech, Inc. | Human nerve growth factor by recombinant technology |
US5453363A (en) | 1985-10-23 | 1995-09-26 | Boehringer Mannheim Gmbh | Process for the activation of t-PA or Ing after genetic expression in prokaryotes |
US5683894A (en) | 1988-04-29 | 1997-11-04 | University Of California | Recombinant nerve growth factor |
US5606031A (en) | 1990-04-06 | 1997-02-25 | Lile; Jack | Production and purification of biologically active recombinant neurotrophic protein in bacteria |
US5235043A (en) * | 1990-04-06 | 1993-08-10 | Synergen, Inc. | Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
DE4139000A1 (de) | 1991-11-27 | 1993-06-03 | Boehringer Mannheim Gmbh | Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf |
DE4405179A1 (de) | 1994-02-18 | 1995-08-24 | Hoechst Ag | Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken |
AU3564595A (en) * | 1994-09-12 | 1996-03-29 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Biologically active molecules derived from neurotrophins |
US5935824A (en) * | 1996-01-31 | 1999-08-10 | Technologene, Inc. | Protein expression system |
ES2214624T3 (es) | 1996-06-11 | 2004-09-16 | Roche Diagnostics Gmbh | Procedimiento de activacion de proteina desnaturalizada. |
ATE257514T1 (de) | 1998-10-09 | 2004-01-15 | Scil Proteins Gmbh | Verfahren zur gewinnung von aktivem beta-ngf |
-
1998
- 1998-10-09 AT AT98119077T patent/ATE257514T1/de active
- 1998-10-09 ES ES98119077T patent/ES2213861T3/es not_active Expired - Lifetime
- 1998-10-09 EP EP98119077A patent/EP0994188B1/de not_active Expired - Lifetime
- 1998-10-09 DE DE59810555T patent/DE59810555D1/de not_active Expired - Lifetime
-
1999
- 1999-10-11 US US09/807,096 patent/US8318671B1/en not_active Expired - Lifetime
- 1999-10-11 KR KR1020017004512A patent/KR100593831B1/ko active IP Right Grant
- 1999-10-11 JP JP2000576009A patent/JP4634611B2/ja not_active Expired - Lifetime
- 1999-10-11 WO PCT/EP1999/007613 patent/WO2000022119A1/de active IP Right Grant
- 1999-10-11 CA CA002346257A patent/CA2346257C/en not_active Expired - Lifetime
- 1999-10-11 AU AU10348/00A patent/AU765810B2/en active Active
-
2001
- 2001-04-04 ZA ZA200102780A patent/ZA200102780B/en unknown
-
2010
- 2010-04-22 US US12/765,229 patent/US8501439B2/en not_active Expired - Lifetime
- 2010-09-06 JP JP2010199387A patent/JP5275306B2/ja not_active Expired - Lifetime
-
2017
- 2017-09-27 FR FR17C0007C patent/FR17C0007I2/fr active Active
- 2017-09-28 NL NL300894C patent/NL300894I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
FR17C0007I1 (fr) | 2017-11-17 |
CA2346257A1 (en) | 2000-04-20 |
AU765810B2 (en) | 2003-10-02 |
ZA200102780B (en) | 2002-07-04 |
CA2346257C (en) | 2005-03-01 |
BR9914393B1 (pt) | 2021-06-22 |
JP5275306B2 (ja) | 2013-08-28 |
DE59810555D1 (de) | 2004-02-12 |
ATE257514T1 (de) | 2004-01-15 |
JP2010280717A (ja) | 2010-12-16 |
JP4634611B2 (ja) | 2011-02-16 |
WO2000022119A1 (de) | 2000-04-20 |
AU1034800A (en) | 2000-05-01 |
EP0994188A1 (de) | 2000-04-19 |
JP2002527062A (ja) | 2002-08-27 |
BR9914393A (pt) | 2001-06-26 |
KR20010083900A (ko) | 2001-09-03 |
NL300894I2 (nl) | 2018-02-01 |
ES2213861T3 (es) | 2004-09-01 |
KR100593831B1 (ko) | 2006-06-28 |
US20100203589A1 (en) | 2010-08-12 |
EP0994188B1 (de) | 2004-01-07 |
US8501439B2 (en) | 2013-08-06 |
US8318671B1 (en) | 2012-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR17C0007I2 (fr) | Procédé d'obtention du NGF-bêta biologiquement actif | |
DE3477810D1 (en) | Polypeptide and protein products, and processes for their production and use | |
PT1305056E (pt) | Enxerto osseo sintetico poroso e processo para a sua fabricacao | |
ATE380822T1 (de) | Funf-helix protein | |
NO20014364D0 (no) | Ny cytokin-zalphall-ligand | |
DK439089D0 (da) | Pulmonarsurfactantproteiner, deres fremstilling og anvendelse, deri indgaaende polypeptider og dna-segmenter samt rekombinantnucleinsyremolekyle, som eksprimerer dem | |
WO2000061768A3 (en) | Preparation of biologically active molecules | |
ES2187782T3 (es) | Procedimiento para la produccion de polipeptidos. | |
EA200100834A1 (ru) | Способ получения 5-цианофталида | |
ES2155278T3 (es) | Procedimiento para producir fibra de poliester y la fibra de poliester obtenida por el mismo. | |
AR069892A1 (es) | Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion. | |
IL153943A0 (en) | SUBSTRATES AND ASSAYS FOR beta-SECRETASE ACTIVITY | |
PT1200561E (pt) | Clone celular recombinante estavel, sua producao e utilizacao | |
AU2001249438A1 (en) | Production of fluormethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether | |
CA2257122A1 (en) | Method of activating denatured protein | |
GB2364233A (en) | Composition for freezing dog sperm method of freezing the dog sperm utilizing the compositions & artificial insemination method employing the frozen dog sperm | |
WO2003051927A3 (en) | Production of f(ab')2 fragments in mammalian cells | |
AR033979A1 (es) | Metodo para preparar un polipeptido il-18 fisiologicamente activo | |
ATE258008T1 (de) | Biologisch aktive mikrodispersionszusammensetzung | |
IT1298267B1 (it) | Procedimento per la preparazione dell'acido (s)-2-acetiltio-3-fenil- propionico e dei suoi sali | |
EA200201003A1 (ru) | Аморфная модификация торасемида | |
BRPI9913018A (pt) | processo para a preparação de somatotropina ativa a partir de corpúsculos de inclusão. | |
ES2184033T3 (es) | Proceso para la preparacion de acido 5-bromo-2-fluorobencenoborico. | |
ES2160117T3 (es) | Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion. | |
CA2359256A1 (en) | Propagation of bovine coronavirus in chinese hamster ovary cells |